Detection of Human Aspartyl (Asparaginyl) Beta-Hydroxylase and Homeobox B7 mRNA in Brush Cytology Specimens from Patients with Bile Duct Cancer

Background and Study Aims: The diagnosis of bile duct cancer is hampered by the low sensitivity of intraductal brush cytology and forceps biopsy. In the present study real-time reverse transcription polymerase chain reaction (RT-PCR) assays for the detection of human aspartyl (asparaginyl) beta-hydroxylase (HAAH) and homeobox B7 (HoxB7) mRNA from intraductal brush cytology specimens were established. Both markers are overexpressed in biliary cancer cell lines and possibly involved in the pathogenesis of bile duct cancer.
Patients and Methods: RT-PCR assays were validated for detection limit, in-assay variability, and inter-assay variability. Target gene expression was determined in brush cytology specimens from 16 patients with biliary strictures (11 with histologically proven cholangiocarcinomas and five with benign biliary strictures).
Results: The assay was quick (about 3 h), highly sensitive (with detection limits between 3 and 106 molecules), and reproducible (maximum in-assay variability 10.3 %, maximum inter-assay variability 11.8 %). The sensitivity of routine brush cytology alone was 36 % (four of 11 cases), with 100 % specificity. A combination with detection of HoxB7 and HAAH mRNA increased the overall diagnostic sensitivity to 82 %.
Conclusions: Detection of these markers using the RT-PCR assays from brush cytology specimens described here may prove to be a useful additional tool for the diagnosis of bile duct carcinoma.

References

• 1 De Groen P C, Gores G J, LaRusso N F. et al . Biliary tract cancers.  N Engl J Med. 1999;  341 1368-1378
• 2 Wiedmann M, Berr F, Schiefke I. et al . Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study.  Gastrointest Endosc. 2004;  60 68-75
• 3 De Bellis M, Sherman S, Fogel E L. et al . Tissue sampling at ERCP in suspected malignant biliary strictures (part 2).  Gastrointest Endosc. 2002;  56 720-730
• 4 Principe A, Ercolani G, Bassi F. et al . Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma.  Hepatogastroenterology. 2003;  50 1246-1249
• 5 Hansel D E, Rahman A, Hidalgo M. et al . Identification of novel cellular targets in biliary tract cancers using global gene expression technology.  Am J Pathol. 2003;  163 217-229
• 6 Enjoji M, Kotoh K, Iwamoto H. et al . Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells.  In Vitro Cell Dev Biol Anim. 2000;  36 71-73
• 7 Lopes Cardozo P. Atlas of clinical cytology: a contribution to precise cytodiagnosis and cytological differential diagnosis. Leiden, Netherlands: s. l., c. 1976;
• 8 Kocjan G, Smith A N. Bile duct brushings cytology: potential pitfalls in diagnosis.  Diagn Cytopathol. 1997;  16 358-363
• 9 Dumoulin F L, Nischalke H D, Leifeld L. et al . Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards.  J Immunol Methods. 2000;  241 109-119
• 10 Morales C P, Burdick J S, Saboorian M H. et al . In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies.  Gastrointest Endosc. 1998;  48 402-405
• 11 Itoi T, Shinohara Y, Takeda K. et al . Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.  Gastrointest Endosc. 2000;  52 380-386
• 12 Niiyama H, Mizumoto K, Kusumoto M. et al . Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.  Cancer. 1999;  85 2138-2143
• 13 Ponsioen C Y, Vrouenraets S M, van Milligen de Wit A W. et al . Value of brush cytology for dominant strictures in primary sclerosing cholangitis.  Endoscopy. 1999;  31 305-309
• 14 Stewart C J, Burke G M. Value of p53 immunostaining in pancreatico-biliary brush cytology specimens.  Diagn Cytopathol. 2000;  23 308-313
• 15 Kipp B R, Stadheim L M, Halling S A. et al . A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures.  Am J Gastroenterol. 2004;  99 1675-1681
• 16 Khalid A, Pal R, Sasatomi E. et al . Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.  Gut. 2004;  53 1860-1865
• 17 Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma.  Semin Liver Dis. 2004;  24 139-154
• 18 Obama K, Ura K, Li M. et al . Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.  Hepatology. 2005;  41 1339-1348
• 19 Lavaissiere L, Jia S, Nishiyama M. et al . Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.  J Clin Invest. 1996;  98 1313-1323
• 20 Ince N, de la Monte S M, Wands J R. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation.  Cancer Res. 2000;  60 1261-1266
• 21 De Bellis M, Sherman S, Fogel E L. et al . Tissue sampling at ERCP in suspected malignant biliary strictures (part 1).  Gastrointest Endosc. 2002;  56 552-561
• 22 Rupp M, Hawthorne C M, Ehya H. Brushing cytology in biliary tract obstruction.  Acta Cytol. 1990;  34 221-226
• 23 Selvaggi S M. Biliary brushing cytology.  Cytopathology. 2004;  15 74-79